ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Anti-Flu Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35E18185
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Pediatric Anti Flu Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Pediatric Anti-Flu Drugs Market Research Report 2025

Code: QYRE-Auto-35E18185
Report
May 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Johnson & Johnson
GlaxoSmithKline(GSK )
Rostec
Cipla Ltd

Pediatric Anti-Flu Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pediatric Anti-Flu Drugs Market

Pediatric Anti-Flu Drugs Market

The global market for Pediatric Anti-Flu Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Anti-Flu Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Anti-Flu Drugs.
The Pediatric Anti-Flu Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Anti-Flu Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Anti-Flu Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Anti-Flu Drugs Market Report

Report Metric Details
Report Name Pediatric Anti-Flu Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Online Sales
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pediatric Anti-Flu Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pediatric Anti-Flu Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pediatric Anti-Flu Drugs Market report?

Ans: The main players in the Pediatric Anti-Flu Drugs Market are Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec, Cipla

What are the Application segmentation covered in the Pediatric Anti-Flu Drugs Market report?

Ans: The Applications covered in the Pediatric Anti-Flu Drugs Market report are Hospital, Clinic, Online Sales, Others

What are the Type segmentation covered in the Pediatric Anti-Flu Drugs Market report?

Ans: The Types covered in the Pediatric Anti-Flu Drugs Market report are Oseltamivir, Zanamivir

Recommended Reports

Pediatric Antivirals

Pediatric Vaccines

Pediatric Healthcare

1 Pediatric Anti-Flu Drugs Market Overview
1.1 Product Definition
1.2 Pediatric Anti-Flu Drugs by Type
1.2.1 Global Pediatric Anti-Flu Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.3 Pediatric Anti-Flu Drugs by Application
1.3.1 Global Pediatric Anti-Flu Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Online Sales
1.3.5 Others
1.4 Global Pediatric Anti-Flu Drugs Market Size Estimates and Forecasts
1.4.1 Global Pediatric Anti-Flu Drugs Revenue 2020-2031
1.4.2 Global Pediatric Anti-Flu Drugs Sales 2020-2031
1.4.3 Global Pediatric Anti-Flu Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Anti-Flu Drugs Market Competition by Manufacturers
2.1 Global Pediatric Anti-Flu Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Anti-Flu Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Anti-Flu Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Anti-Flu Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Date of Enter into This Industry
2.8 Global Pediatric Anti-Flu Drugs Market Competitive Situation and Trends
2.8.1 Global Pediatric Anti-Flu Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Anti-Flu Drugs Players Market Share by Revenue
2.8.3 Global Pediatric Anti-Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Anti-Flu Drugs Market Scenario by Region
3.1 Global Pediatric Anti-Flu Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Anti-Flu Drugs Sales by Region: 2020-2031
3.2.1 Global Pediatric Anti-Flu Drugs Sales by Region: 2020-2025
3.2.2 Global Pediatric Anti-Flu Drugs Sales by Region: 2026-2031
3.3 Global Pediatric Anti-Flu Drugs Revenue by Region: 2020-2031
3.3.1 Global Pediatric Anti-Flu Drugs Revenue by Region: 2020-2025
3.3.2 Global Pediatric Anti-Flu Drugs Revenue by Region: 2026-2031
3.4 North America Pediatric Anti-Flu Drugs Market Facts & Figures by Country
3.4.1 North America Pediatric Anti-Flu Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Anti-Flu Drugs Sales by Country (2020-2031)
3.4.3 North America Pediatric Anti-Flu Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Anti-Flu Drugs Market Facts & Figures by Country
3.5.1 Europe Pediatric Anti-Flu Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Anti-Flu Drugs Sales by Country (2020-2031)
3.5.3 Europe Pediatric Anti-Flu Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Anti-Flu Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Anti-Flu Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Anti-Flu Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Anti-Flu Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Anti-Flu Drugs Market Facts & Figures by Country
3.7.1 Latin America Pediatric Anti-Flu Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Anti-Flu Drugs Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Anti-Flu Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pediatric Anti-Flu Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Anti-Flu Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Anti-Flu Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Anti-Flu Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Anti-Flu Drugs Sales by Type (2020-2031)
4.1.1 Global Pediatric Anti-Flu Drugs Sales by Type (2020-2025)
4.1.2 Global Pediatric Anti-Flu Drugs Sales by Type (2026-2031)
4.1.3 Global Pediatric Anti-Flu Drugs Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Anti-Flu Drugs Revenue by Type (2020-2031)
4.2.1 Global Pediatric Anti-Flu Drugs Revenue by Type (2020-2025)
4.2.2 Global Pediatric Anti-Flu Drugs Revenue by Type (2026-2031)
4.2.3 Global Pediatric Anti-Flu Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Anti-Flu Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Anti-Flu Drugs Sales by Application (2020-2031)
5.1.1 Global Pediatric Anti-Flu Drugs Sales by Application (2020-2025)
5.1.2 Global Pediatric Anti-Flu Drugs Sales by Application (2026-2031)
5.1.3 Global Pediatric Anti-Flu Drugs Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Anti-Flu Drugs Revenue by Application (2020-2031)
5.2.1 Global Pediatric Anti-Flu Drugs Revenue by Application (2020-2025)
5.2.2 Global Pediatric Anti-Flu Drugs Revenue by Application (2026-2031)
5.2.3 Global Pediatric Anti-Flu Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Anti-Flu Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Pediatric Anti-Flu Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Pediatric Anti-Flu Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 GlaxoSmithKline (GSK)
6.3.1 GlaxoSmithKline (GSK) Company Information
6.3.2 GlaxoSmithKline (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Portfolio
6.3.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.4 Rostec
6.4.1 Rostec Company Information
6.4.2 Rostec Description and Business Overview
6.4.3 Rostec Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Rostec Pediatric Anti-Flu Drugs Product Portfolio
6.4.5 Rostec Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Pediatric Anti-Flu Drugs Product Portfolio
6.5.5 Cipla Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Anti-Flu Drugs Industry Chain Analysis
7.2 Pediatric Anti-Flu Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Anti-Flu Drugs Production Mode & Process Analysis
7.4 Pediatric Anti-Flu Drugs Sales and Marketing
7.4.1 Pediatric Anti-Flu Drugs Sales Channels
7.4.2 Pediatric Anti-Flu Drugs Distributors
7.5 Pediatric Anti-Flu Drugs Customer Analysis
8 Pediatric Anti-Flu Drugs Market Dynamics
8.1 Pediatric Anti-Flu Drugs Industry Trends
8.2 Pediatric Anti-Flu Drugs Market Drivers
8.3 Pediatric Anti-Flu Drugs Market Challenges
8.4 Pediatric Anti-Flu Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Johnson & Johnson
GlaxoSmithKline(GSK )
Rostec
Cipla Ltd
List of Tables
 Table 1. Global Pediatric Anti-Flu Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pediatric Anti-Flu Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pediatric Anti-Flu Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pediatric Anti-Flu Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pediatric Anti-Flu Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pediatric Anti-Flu Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pediatric Anti-Flu Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pediatric Anti-Flu Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pediatric Anti-Flu Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pediatric Anti-Flu Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Anti-Flu Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pediatric Anti-Flu Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pediatric Anti-Flu Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Pediatric Anti-Flu Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Pediatric Anti-Flu Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Pediatric Anti-Flu Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Pediatric Anti-Flu Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pediatric Anti-Flu Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pediatric Anti-Flu Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pediatric Anti-Flu Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pediatric Anti-Flu Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pediatric Anti-Flu Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pediatric Anti-Flu Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pediatric Anti-Flu Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pediatric Anti-Flu Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pediatric Anti-Flu Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pediatric Anti-Flu Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pediatric Anti-Flu Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pediatric Anti-Flu Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pediatric Anti-Flu Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pediatric Anti-Flu Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pediatric Anti-Flu Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pediatric Anti-Flu Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pediatric Anti-Flu Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pediatric Anti-Flu Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pediatric Anti-Flu Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pediatric Anti-Flu Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pediatric Anti-Flu Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pediatric Anti-Flu Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pediatric Anti-Flu Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pediatric Anti-Flu Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pediatric Anti-Flu Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Pediatric Anti-Flu Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Pediatric Anti-Flu Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Pediatric Anti-Flu Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Pediatric Anti-Flu Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pediatric Anti-Flu Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pediatric Anti-Flu Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Pediatric Anti-Flu Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pediatric Anti-Flu Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Pediatric Anti-Flu Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Pediatric Anti-Flu Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Pediatric Anti-Flu Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Pediatric Anti-Flu Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pediatric Anti-Flu Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pediatric Anti-Flu Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Pediatric Anti-Flu Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Pediatric Anti-Flu Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Pediatric Anti-Flu Drugs Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. GlaxoSmithKline (GSK) Company Information
 Table 81. GlaxoSmithKline (GSK) Description and Business Overview
 Table 82. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product
 Table 84. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 85. Rostec Company Information
 Table 86. Rostec Description and Business Overview
 Table 87. Rostec Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Rostec Pediatric Anti-Flu Drugs Product
 Table 89. Rostec Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cipla Pediatric Anti-Flu Drugs Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Pediatric Anti-Flu Drugs Distributors List
 Table 98. Pediatric Anti-Flu Drugs Customers List
 Table 99. Pediatric Anti-Flu Drugs Market Trends
 Table 100. Pediatric Anti-Flu Drugs Market Drivers
 Table 101. Pediatric Anti-Flu Drugs Market Challenges
 Table 102. Pediatric Anti-Flu Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pediatric Anti-Flu Drugs
 Figure 2. Global Pediatric Anti-Flu Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Anti-Flu Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oseltamivir Product Picture
 Figure 5. Zanamivir Product Picture
 Figure 6. Global Pediatric Anti-Flu Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pediatric Anti-Flu Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Online Sales
 Figure 11. Others
 Figure 12. Global Pediatric Anti-Flu Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pediatric Anti-Flu Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pediatric Anti-Flu Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Pediatric Anti-Flu Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pediatric Anti-Flu Drugs Report Years Considered
 Figure 17. Pediatric Anti-Flu Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Pediatric Anti-Flu Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pediatric Anti-Flu Drugs Players: Market Share by Revenue in Pediatric Anti-Flu Drugs in 2024
 Figure 20. Pediatric Anti-Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pediatric Anti-Flu Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pediatric Anti-Flu Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Pediatric Anti-Flu Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pediatric Anti-Flu Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pediatric Anti-Flu Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pediatric Anti-Flu Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pediatric Anti-Flu Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pediatric Anti-Flu Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pediatric Anti-Flu Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pediatric Anti-Flu Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pediatric Anti-Flu Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pediatric Anti-Flu Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pediatric Anti-Flu Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pediatric Anti-Flu Drugs by Type (2020-2031)
 Figure 54. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pediatric Anti-Flu Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pediatric Anti-Flu Drugs by Application (2020-2031)
 Figure 57. Global Pediatric Anti-Flu Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pediatric Anti-Flu Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Antiviral Drugs Market
Global Pediatric Oncology Treatment Market Research Report 2025
Global Infant and Baby Cold Medicine Market Research Report 2025
Global Influenza Drugs and Vaccines Market Research Report 2025
Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paediatric Vaccine Market
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Anti Infectives Market Research Report 2025
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Global Inhaled Anti Infectives Market Research Report 2025
Global Baby Teething Drugs Market Research Report 2025
Inactivated Influenza Vaccine Market
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Child Bone Age Auxiliary Diagnosis System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions